Amneal Pharmaceuticals Inc
For the period ended Dec 31, 2023. Filed Mar 14, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 14, 2024
AMRX$21.38+0.5%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Changes in Stockholders Equity
| Old PubCo · New PubCo | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock · Class B Common Stock · Class A Common Stock · AdditionalPaid-inCapital · Stockholders’AccumulatedDeficit · AccumulatedOtherComprehensiveIncome (Loss) · Non-ControllingInterests · TotalEquity · RedeemableNon-Controlling Interests | ||||||||||||
| Shares · Amount · Shares · Amount · Shares · Amount | ||||||||||||
| Balance at December 31, 2022 | 151,490 | $1,514 | 152,117 | $1,522 | — | $— | $691,629 | $(406,183) | $9,939 | $(114,442) | $183,979 | $24,949 |
| Net (loss) income | — | — | — | — | — | — | — | (83,993) | — | 4,728 | (79,265) | 30,543 |
| Foreign currency translation adjustments | — | — | — | — | — | — | — | — | (433) | (626) | (1,059) | — |
| Stock-based compensation | — | — | — | — | — | — | 26,822 | — | — | — | 26,822 | — |
| Exercise of stock options | 148 | 1 | — | — | 15 | 1 | 447 | — | 4 | (2) | 451 | — |
| Restricted stock unit vesting, net of shares withheld to cover payroll taxes | 2,789 | 28 | — | — | 6 | — | 2,594 | — | 77 | (5,069) | (2,370) | — |
| Unrealized loss on cash flow hedge, net of tax | — | — | — | — | — | — | — | — | (39,248) | (9,249) | (48,497) | — |
| Tax distributions, net | — | — | — | — | — | — | — | — | — | (56,684) | (56,684) | (14,199) |
| Reclassification of cash flow hedge to earnings, net of tax | — | — | — | — | — | — | — | — | (3,366) | — | (3,366) | — |
| Effect of the Reorganization | (154,427) | (1,543) | (152,117) | (1,522) | 306,544 | 3,065 | (182,252) | — | 678 | 181,574 | — | — |
| Balance at December 31, 2023 | — | $— | — | $— | 306,565 | $3,066 | $539,240 | $(490,176) | $(32,349) | $230 | $20,011 | $41,293 |
| Old PubCo | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock · Class B Common Stock · AdditionalPaid-inCapital · Stockholders’AccumulatedDeficit · AccumulatedOtherComprehensiveLoss · Non-ControllingInterests · TotalEquity · RedeemableNon-Controlling Interests | ||||||||||
| Shares · Amount · Shares · Amount | ||||||||||
| Balance at December 31, 2021 | 149,413 | $1,492 | 152,117 | $1,522 | $658,350 | $(276,197) | $(24,827) | $6,633 | $366,973 | $16,907 |
| Net (loss) income | — | — | — | — | — | (129,548) | — | (141,036) | (270,584) | 15,795 |
| Foreign currency translation adjustments | — | — | — | — | — | — | (13,394) | (13,497) | (26,891) | — |
| Stock-based compensation | — | — | — | — | 31,847 | — | — | — | 31,847 | — |
| Exercise of stock options | 207 | 2 | — | — | 615 | — | — | 45 | 662 | — |
| Restricted stock unit vesting, net of shares withheld to cover payroll taxes | 1,870 | 20 | — | — | 817 | — | (110) | (4,289) | (3,562) | — |
| Unrealized gain on cash flow hedge, net of tax | — | — | — | — | — | — | 48,270 | 48,789 | 97,059 | — |
| Tax distributions, net | — | — | — | — | — | — | — | (10,642) | (10,642) | (6,914) |
| Reclassification of redeemable non-controlling interests | — | — | — | — | — | (438) | — | (445) | (883) | 883 |
| Acquisition of non-controlling interest from Puniska Acquisition | — | — | — | — | — | — | — | — | — | (1,722) |
| Balance at December 31, 2022 | 151,490 | $1,514 | 152,117 | $1,522 | $691,629 | $(406,183) | $9,939 | $(114,442) | $183,979 | $24,949 |
| Old PubCo | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock · Class B Common Stock · AdditionalPaid-inCapital · Stockholders’AccumulatedDeficit · AccumulatedOtherComprehensiveLoss · Non-ControllingInterests · TotalEquity · Redeemable Non-Controlling Interests | ||||||||||
| Shares · Amount · Shares · Amount | ||||||||||
| Balance at December 31, 2020 | 147,674 | $1,475 | 152,117 | $1,522 | $628,413 | $(286,821) | $(41,318) | $41,661 | $344,932 | $11,804 |
| Net income | — | — | — | — | — | 10,624 | — | 2,539 | 13,163 | 7,007 |
| Foreign currency translation adjustments | — | — | — | — | — | — | (4,255) | (4,363) | (8,618) | — |
| Stock-based compensation | — | — | — | — | 28,412 | — | — | — | 28,412 | — |
| Exercise of stock options | 342 | 3 | — | — | 901 | — | (44) | (7) | 853 | — |
| Restricted stock unit vesting, net of shares withheld to cover payroll taxes | 1,397 | 14 | — | — | 624 | — | (182) | (3,169) | (2,713) | — |
| Unrealized gain on cash flow hedge, net of tax | — | — | — | — | — | — | 20,972 | 21,458 | 42,430 | — |
| Tax distributions | — | — | — | — | — | — | — | (53,486) | (53,486) | (3,646) |
| Non-controlling interests from KSP Acquisition | — | — | — | — | — | — | — | 2,000 | 2,000 | — |
| Non-controlling interests from Puniska Acquisition | — | — | — | — | — | — | — | — | — | 1,742 |
| Balance at December 31, 2021 | 149,413 | $1,492 | 152,117 | $1,522 | $658,350 | $(276,197) | $(24,827) | $6,633 | $366,973 | $16,907 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.